Free shipping on all orders over $ 500

RS102895

Cat. No. M11028

All AbMole products are for research use only, cannot be used for human consumption.

RS102895  Structure
Synonym:

Abaucin; MLJS-21001

Size Price Availability Quantity
1mg USD 35 In stock
5mg USD 65 In stock
10mg USD 110 In stock
25mg USD 200 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

RS102895 is a potent CCR2 antagonist, with IC50 value of 360 nM. RS102895 also inhibits human α1a and α1d receptors, rat brain cortex 5HT1a receptor in cells with IC50s of 130, 320, 470 nM, respectively. RS102895 suppresses wild type and D284N mutant MCP-1 receptor (IC50, 550 nM and 568 nM, respectively), less potently inhibits D284A MCP-1 receptor (IC50, 1892 nM), and has no effects on E291A, E291Q, D284A/E291A or D284N/E291Q (IC50, >100,000 nM). RS102895 ameliorates the increased extracellular matrix (ECM) protein expression by inhibition of CCR2 at 10 μM, and obviously blocks fibronectin and type IV collagen protein expression in high glucose (HG)-stimulated mesangial cells (MCs) at 1 or 10 μM. RS102895 (3 g/L) causes progressive decrease in pain threshold in rats with bone cancer pain (BCP) at day 3-9 after surgery via intrathecal injection, but the pain threshold increases after 12 days.

Chemical Information
Molecular Weight 390.4
Formula C21H21F3N2O2
CAS Number 300815-41-2
Solubility (25°C) DMSO ≥ 90 mg/mL
Ethanol 40 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Jingzhou Wang, et al. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. [RS102895 inhibits the proliferation, invasion, and migration of PC-3 prostate cancer cells by blocking CCL2/CCR2 pathway]

[2] Swati Singh, et al. Front Cell Neurosci. CCR2 Inhibition Reduces Neurotoxic Microglia Activation Phenotype After Japanese Encephalitis Viral Infection

[3] Leyuan Xu, et al. J Am Soc Nephrol. Tubular GM-CSF Promotes Late MCP-1/CCR2-Mediated Fibrosis and Inflammation after Ischemia/Reperfusion Injury

[4] Su Jin Seok, et al. Nephrol Dial Transplant. Blockade of CCL2/CCR2 signalling ameliorates diabetic nephropathy in db/db mice

[5] Leah A Mitchell, et al. Int Immunopharmacol. Optimized dosing of a CCR2 antagonist for amplification of vaccine immunity

Related CCR Products
Maraviroc

Maraviroc (UK-427857) is a selective CCR5 antagonist with potent anti-human immunodeficiency virus type 1 (HIV-1) activity and favorable pharmacological properties.

Vicriviroc Malate

Vicriviroc (SCH 417690) is a pyrimidine CCR5 entry inhibitor of HIV-1 with IC50 of 0.91 nM.

Bindarit

Bindarit (AF2838) is a selective inhibitor of the monocyte chemotactic proteins MCP-1/CCL2, MCP-3/CCL7 and MCP-2/CCL8. Bindarit also has anti-inflammatory activity.

BMS-813160

BMS-813160 is the first dual CCR2/CCR5 antagonist. BMS-813160 binds with CCR2, CCR5, CCR1, CCR4 and CXCR2 with IC50s of 6.2 nM, 3.6 nM, >25 μM, >40 μM and >40 μM, respectively.

INCB3284 dimesylate

INCB 3284 dimesylate is a potent, selective and orally bioavailable hCCR2 antagonist with IC50 of 3.7 nM.

  Catalog
Abmole Inhibitor Catalog




Keywords: RS102895 , Abaucin; MLJS-21001 supplier, CCR, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.